Chunshan Xie

Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode.

David S. Nirschl, Kimberly A. Foster, David S Nirschl, 2017, Journal of medicinal chemistry.

Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties

M. D. Hill, Derek J. Norris, J. Tokarski, 2022, ACS Medicinal Chemistry Letters.

Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype.

M. D. Hill, J. Tokarski, S. Sheriff, 2021, Bioorganic & medicinal chemistry letters.

Synthesis, structure-activity relationship studies and evaluation of a TLR 3/8/9 agonist and its analogues

D. Boger, J. Naglich, Anindya Sarkar, 2021, Medicinal Chemistry Research.

DNA-Model-Based Design and Execution of Some Fused Benzodiazepine Hybrid Payloads for Antibody-Drug Conjugate Modality.

Martin D. Eastgate, D. Langley, I. Mcdonald, 2021, ACS medicinal chemistry letters.

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

I McNiece, Ying Sun, Y. Sun, 1994, Molecular and cellular biology.

Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology.

Murugaiah A. M. Subbaiah, G. Schieven, A. Mathur, 2024, ACS medicinal chemistry letters.

Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology.

G. Schieven, A. Mathur, D. Critton, 2024, ACS medicinal chemistry letters.